Evidence map›Paper›PMID 38515807›Full record

ArticleDialogues in health2023

Banning asbestos in talcum powder: Time for action in India.

Shalini Singh, Sanchita Roy Pradhan, Amit Yadav, Prashant Kumar Singh

Open access · goldAbstract read
In one paragraph

Article in Dialogues in health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Marble Waste Dump Yard in Rajasthan, India Revealed as a Potential Asbestos Exposure Hazard.International journal of environmental research and public health · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Shalini SinghICMR- National Institute of Cancer Prevention and Research (NICPR), Ministry of Health and Family Welfare, Government of India. I - 7, Sector - 39, NOIDA, Gautam Buddha Nagar, Uttar Pradesh 201301, India.
Sanchita Roy PradhanICMR- National Institute of Cancer Prevention and Research (NICPR), Ministry of Health and Family Welfare, Government of India. I - 7, Sector - 39, NOIDA, Gautam Buddha Nagar, Uttar Pradesh 201301, India.
Amit YadavInternational Union Against Tuberculosis and Lung Disease (The Union).
Prashant Kumar SinghICMR- National Institute of Cancer Prevention and Research (NICPR), Ministry of Health and Family Welfare, Government of India. I - 7, Sector - 39, NOIDA, Gautam Buddha Nagar, Uttar Pradesh 201301, India.
National Institute of Cancer Prevention and Research · INGovernment of India · INInternational Union Against Tuberculosis and Lung Disease · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term use of asbestos-contaminated talcum power has been reported to be the main causative agent for carcinogenesis in many research studies. In recent developments Johnson & Johnson has lost multimillion-dollar lawsuits for being associated with the development of mesothelioma and ovarian cancer by its talc-based baby powder. In May 2020, the company announced, the end of the sale of its baby powder in the USA and Canada and in August 2022, announced the global discontinuation by 2023. However, in India vast proportions of people are using talc-based baby powder and the products are readily available in the market. The purpose of this communication is to create awareness and draw attention of authorities for effective regulation, including prohibition of sale and retraction of the contaminated talc-based products from the Indian market at the earliest.

Identifiers

PMID38515807
PMCPMC10953941
OpenAlexW4388594989

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.